Tech Company Financing Transactions
Harpoon Therapeutics Funding Round
Harpoon Therapeutics, based in San Francisco, secured $15 million from MPM Capital.
Transaction Overview
Company Name
Announced On
3/31/2016
Transaction Type
Venture Equity
Amount
$15,000,000
Round
Undisclosed
Investors
MPM Capital (Luke Evnin)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
131 Oyster Point Blvd. 300
San Francisco, CA 94080
USA
San Francisco, CA 94080
USA
Phone
Website
Email Address
Overview
Harpoon Therapeutics (Nasdaq: HARP) is an immuno-oncology company developing a novel class of T cell engagers that unleash the natural power of the T cells to fight cancer and other diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Gerald McMahon
Chief Financial Officer
Georgia Erbez
Chief Medical Officer
Natalie Sacks
Chief Scientific Officer
Holger Wesche
Vice President
Che-Leung Law
VP - Bus. Development
Rachael Lester
VP - Finance
Christopher Whitmore
VP - Product Management
Susan Jones
Browse more venture capital transactions:
Prev: 3/31/2016: Autonomous Marine Systems venture capital transaction
Next: 3/31/2016: Biomeme venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. All VC database entries on this site are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs